Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Olaparib
2023/3610 NEOSARC
Phase 2 small_molecule active
Quick answer
Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Olaparib for Undifferentiated pleomorphic sarcoma and Dedifferentiated liposarcoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Undifferentiated pleomorphic sarcoma and Dedifferentiated liposarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active